Back
Emergent BioSolutions Vs. Viking Therapeutics Industry Stock Comparison
Buy
67
EBS
Emergent BioSolutions
Last Price:
5.27
Seasonality Move:
6.46%
Buy
57
VKTX
Viking Therapeutics
Last Price:
69.16
Seasonality Move:
16.7%
Buy
67
Emergent BioSolutions (EBS)
is a Buy
Is Emergent BioSolutions a Buy, Sell or Hold?
- The current Emergent BioSolutions [EBS] share price is $5.27. The Score for EBS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- EBS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $69.06. The Score for VKTX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EBS Stock Price Chart
What is Emergent BioSolutions's stock price today?
-
The Emergent BioSolutions share price today is $5.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EBS is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $69.06
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
EBS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.82 | Buy |
| Relative Strength Index (14 RSI): | 73.38 | Buy |
| Chaikin Money Flow: | -1762606 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 4.47) | Buy |
| Bollinger Bands (100): | (1.6 - 3.36) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 44.32 | Sell |
| Chaikin Money Flow: | -6295966 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.49 - 77.73) | Sell |
| Bollinger Bands (100): | (27.53 - 78.25) | Buy |
EBS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Buy |
| 20-day SMA: | 3.42 | Buy |
| 50-day SMA: | 2.77 | Buy |
| 200-day SMA: | 2.91 | Buy |
| 8-day EMA: | 4.81 | Buy |
| 20-day EMA: | 3.87 | Buy |
| 50-day EMA: | 3.08 | Buy |
| 200-day EMA: | 4.15 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.66 | Sell |
| 20-day SMA: | 73.4 | Sell |
| 50-day SMA: | 72.21 | Sell |
| 200-day SMA: | 33 | Buy |
| 8-day EMA: | 74.25 | Sell |
| 20-day EMA: | 73.95 | Sell |
| 50-day EMA: | 68.67 | Buy |
| 200-day EMA: | 42.08 | Buy |
Emergent BioSolutions Earnings Growth & EBS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.88 per share, and an increase next year of $0.85 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
Emergent BioSolutions Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||